A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Description

The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

Conditions

Surgery

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

A Multi-Disciplinary Approach to the Opportunistic Salpingectomy for Primary Prevention of Ovarian Cancer

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Condition
Surgery
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University (Data Collection Only), Baltimore, Maryland, United States, 21287

Boston

Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States, 02115

Basking Ridge

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States, 07920

Middletown

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States, 07748

Montvale

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States, 07645

Commack

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack, New York, United States, 11725

Harrison

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States, 10604

New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States, 10065

Uniondale

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States, 11553

Houston

MD Anderson Cancer Center (Data Collection Only), Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥45 years
  • * Scheduled visit with a nongynecologic surgeon
  • * Female or assigned female at birth
  • * Age ≥45 years
  • * At least one in situ fallopian tube
  • * No desire or plan to have children in the future
  • * Average risk of developing ovarian cancer
  • * Planned nongynecologic, intraabdominal, or pelvic surgery
  • * Deemed to be a suitable candidate by gynecologic surgeon and primary nongynecologic surgeon (for example, on the basis of surgical history and current malignancy status)
  • * Approved and signed informed consent
  • * Not fluent in English
  • * Known inherited ovarian cancer susceptibility
  • * Personal history of a gynecologic malignancy
  • * Carrier of a hereditary breast or ovarian cancer variant (e.g., BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2)
  • * Suspicious ovarian, fallopian tube, or uterine lesion on preoperative imaging
  • * Previous bilateral salpingectomy or bilateral salpingo-oophorectomy
  • * Current pregnancy
  • * Emergent procedure or emergency procedure that has to be completed within 24 hours where clinical consent occurs in the inpatient setting or where the patient's immediate well-being is in danger or condition may be life threatening
  • * Primary surgeon anticipates that OS will add significant time (\>30-40min) to the planned procedure.
  • * Inability to access the pelvis (ex., patient prone/lateral position) during the planned procedure.
  • * Known history of pelvic fibrosis or significant adhesions.
  • * Procedures with palliative intent only

Ages Eligible for Study

45 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Kara Long Roche, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2028-03-08